Claims for Patent: 10,300,180

Summary for Patent: 10,300,180

Title:	Wound care and infusion method and system utilizing a therapeutic agent
Abstract:	A wound-care system includes a first pump fluidly coupled to an oxygen source. An oxygen concentrator is fluidly coupled to the first pump. A humidification system is fluidly coupled to the oxygen concentrator. A wound dressing is fluidly coupled to the humidification system and to an exudate chamber. A negative-pressure tube fluidly is coupled to the exudate chamber. A first valve is disposed between the first pump and the oxygen concentrator. A second valve is disposed between the oxygen concentrator and the wound dressing. A third valve is disposed in the negative-pressure tube. Selective activation of the first pump, the first valve, the second valve, and the third valve facilitates delivery of at least one of individual, sequential, or simultaneous negative-pressure treatment and oxygen-rich fluid treatment to the wound via the wound dressing.
Inventor(s):	Quisenberry; Tony (Highland Village, TX), McSpadden; Sam K. (Austin, TX), Balachandran; Niran (Lewisville, TX), Lasalle; Robert K. (Gainesville, TX), Anderson; Thomas C. (Frisco, TX), Davis; Kathryn (Trophy Club, TX)
Assignee:	ThermoTek, Inc. (Flower Mound, TX)
Application Number:	15/730,421
Patent Claims:	1. A wound-care system comprising: a first pump fluidly coupled to an oxygen source; an oxygen concentrator fluidly coupled to the first pump; a humidification system fluidly coupled to the oxygen concentrator; a wound dressing fluidly coupled to the humidification system and to an exudate chamber; a negative-pressure tube fluidly coupled to the exudate chamber; a first pressure sensor exposed to pressure in the negative-pressure tube; a second pressure sensor exposed to pressure between the oxygen concentrator and the wound dressing; a first valve disposed between the first pump and the oxygen concentrator, the first valve being operable to selectively direct flow of fluid from the first pump to at least one of the oxygen concentrator and the humidification system; a second valve disposed between the oxygen concentrator and the wound dressing, the second valve being operable to selectively vent the wound dressing to an exterior environment; a third valve disposed in the negative-pressure tube, the third valve being operable to selectively vent the wound dressing to the exterior environment; and wherein selective activation of the first pump, the first valve, the second valve, and the third valve facilitates delivery of at least one of individual, sequential, or simultaneous negative-pressure treatment and oxygen-rich fluid treatment to the wound via the wound dressing. 2. The wound-care system of claim 1, wherein: the negative-pressure tube is fluidly coupled to an inlet of the first pump; and a fourth valve is disposed in the negative-pressure tube. 3. The wound-care system of claim 1, comprising: a second pump fluidly coupled to the negative-pressure tube; and wherein selective activation of the first pump and the second pump facilitates delivery of at least one of individual, sequential, or simultaneous oxygen-rich fluid treatment and negative-pressure treatment. 4. The wound-care system of claim 3, wherein the second pump configured to apply negative pressure to a wound via the wound dressing. 5. The wound-care system of claim 3, wherein the first pump and the second pump are operated independently of each other. 6. The wound-care system of claim 1, wherein: the humidification system comprises a proton-exchange tube; oxygen-rich fluid is circulated through the proton-exchange tube; and an exterior of the proton-exchange tube is exposed to ambient fluid. 7. The wound-care system of claim 1, wherein the humidification system comprises a channel disposed in a disposable container, the channel containing sterile water through which oxygen-rich fluid discharged from the oxygen concentrator. 8. The wound-care system of claim 1, wherein the oxygen concentrator is a pressure-swing adsorption device. 9. The wound-care system of claim 1, further comprising a disposable canister arranged upstream of the wound dressing. 10. A wound-care system comprising: a first pump fluidly coupled to an oxygen source; a humidification system fluidly coupled to the first pump; and a wound dressing fluidly coupled to the humidification system and to an exudate chamber; a negative-pressure tube fluidly coupled to the exudate chamber; a first pressure sensor exposed to pressure in the negative-pressure tube; a second pressure sensor exposed to pressure between the first pump and the wound dressing; a first valve disposed between the first pump and the humidification system, the first valve being operable to selectively direct flow of fluid from the first pump to the humidification system; a second valve disposed between the first pump and the wound dressing, the second valve being operable to selectively vent the wound dressing to an exterior environment; a third valve disposed in the negative-pressure tube, the third valve being operable to selectively vent the wound dressing to the exterior environment; and wherein selective activation of the first pump, the first valve, and the second valve, facilitates delivery of at least one of individual, sequential, or simultaneous negative-pressure treatment and oxygen-rich fluid treatment to the wound via the wound dressing. 11. The wound-care system of claim 10, wherein: the negative-pressure tube is fluidly coupled to an inlet of the first pump; and a fourth valve is disposed in the negative-pressure tube. 12. The wound-care system of claim 10, comprising: a second pump fluidly coupled to the negative-pressure tube; and wherein selective activation of the first pump and the second pump facilitates delivery of at least one of individual, sequential, or simultaneous oxygen-rich fluid treatment and negative-pressure treatment to the wound via the wound dressing. 13. The wound-care system of claim 10, wherein the oxygen source is an oxygen concentrator.

Details for Patent 10,300,180

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2010-03-19